Purchases and Sales Made in Q4 2023 in Applied Therapeutics Inc. (APLT)
This table provides information about the institutional ownership of Applied Therapeutics Inc. (APLT) during Q4 2023. The information is specifically focused on institutions that hold shares of Applied Therapeutics Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Wolverine Trading, LLC
Chicago, IL |
BUY
|
- |
10.1KNew |
$18.6K - $33.9K
|
10.1K
$7.17K
|
|
|
Jun 03, 2024
Q4 2023
|
Vontobel Holding Ltd.
|
BUY
|
- |
10KNew |
$18.4K - $33.5K
|
10K
$7.1K
|
|
|
Jan 29, 2024
Q4 2023
|
Vontobel Holding Ltd.
|
BUY
|
- |
10KNew |
$18.4K - $33.5K
|
10K
$7.1K
|
|
|
Feb 13, 2024
Q4 2023
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
7.65K+ 7.73% |
$14.1K - $25.6K
|
107K
$75.7K
|
|
|
Feb 14, 2024
Q4 2023
|
State Street Corp
Boston, MA |
BUY
|
- |
3.4K+ 2.48% |
$6.26K - $11.4K
|
141K
$99.9K
|
|
|
Feb 14, 2024
Q4 2023
|
Point72 Asia (Singapore) Pte. Ltd.
Singapore, U0 |
BUY
|
- |
2.9KNew |
$5.34K - $9.72K
|
2.9K
$2.06K
|
|
|
Feb 13, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
2.25K+ 4.38% |
$4.14K - $7.54K
|
53.6K
$38.1K
|
|
|
Feb 14, 2024
Q4 2023
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
2.06K+ 2510.98% |
$3.79K - $6.9K
|
2.14K
$1.52K
|
|
|
Feb 07, 2024
Q4 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 09, 2024
Q4 2023
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-76- 15.08% |
$140 - $255
|
428
$304
|
|
|
Dec 26, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-1.38K- 2.86% |
$2.54K - $4.62K
|
46.9K
$33.3K
|
|
|
Feb 13, 2024
Q4 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-12.3K- 34.61% |
$22.6K - $41.1K
|
23.2K
$16.5K
|
|
|
Oct 21, 2024
Q4 2023
|
Jump Financial, LLC
Chicago, IL |
SELL
|
- |
-29.1K- 54.6% |
$53.5K - $97.4K
|
24.2K
$17.2K
|
|
|
Feb 14, 2024
Q4 2023
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-71.3K- 35.08% |
$131K - $239K
|
132K
$93.7K
|
|
|
Feb 14, 2024
Q4 2023
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-122K- 87.8% |
$225K - $410K
|
17K
$12.1K
|
|
|
Feb 13, 2024
Q4 2023
|
Eam Investors, LLC
Solana Beach, CA |
SELL
|
- |
-209K- 53.3% |
$384K - $699K
|
183K
$130K
|
|
|
Feb 14, 2024
Q4 2023
|
Parkman Healthcare Partners LLC
Stamford, CT |
SELL
|
- |
-731K- 41.76% |
$1.34M - $2.45M
|
1.02M
$724K
|
|
|
Feb 14, 2024
Q4 2023
|
Soleus Capital Management, L.P.
Greenwich, CT |
SELL
|
- |
-732K- 61.36% |
$1.35M - $2.45M
|
461K
$327K
|
|
|
Feb 09, 2024
Q4 2023
|
Franklin Resources Inc
San Mateo, CA |
SELL
|
- |
-929K- 11.69% |
$1.71M - $3.11M
|
7.02M
$4.98M
|
|
|
Feb 14, 2024
Q4 2023
|
Alyeska Investment Group, L.P.
Chicago, IL |
SELL
|
- |
-1.83M- 41.22% |
$3.36M - $6.12M
|
2.6M
$1.85M
|
|
|
Aug 16, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-3.47M- 98.48% |
$6.38M - $11.6M
|
53.6K
$38.1K
|